Liver and spleen imaging
It is recommended that imaging of the liver and spleen is performed to confirm and extend clinical findings associated with a diagnosis of Gaucher disease. Imaging can also be used to detect parenchymatous lesions (e.g. nodules or sequelae of infarction) and gallstones, which may occur in patients with Gaucher disease.2,3 In general, hepatomegaly is defined as liver mass >1.25-times the estimated normal volume, which is 2.5% of total body weight, and splenomegaly as >0.2% of total body weight in kilograms.4 In patients with intact spleens, hepatomegaly is almost always present but is often not massive unless massive splenomegaly is also present.5 Liver function may be normal in patients, although excess blood bilirubin may be observed in patients of Ashkenazi Jewish ethnicity due to Gilbert syndrome: mild jaundice due to increased amounts of unconjugated bilirubin in the plasma without evidence of liver damage.1,6 Moreover, Gaucher disease has also been linked to hypergammaglobulinaemia and hyperferritinaemia.7
Bone manifestations of Gaucher disease
Bone involvement in Gaucher disease is heterogeneous and, in general, is caused by infiltration of Gaucher cells to bone marrow, extending from the axial to the appendicular skeleton. In Gaucher disease, it is often the lower extremities and proximal sites that are affected, whereas the epiphyses are usually spared, except in patients with advanced disease.8 In most patients with Gaucher disease, bone disease is progressively develops over many years and is considered one of the most debilitating aspects of the disease, affecting quality of life.9